The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biopharmaceutical Excipients Market Research Report 2025

Global Biopharmaceutical Excipients Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1487082

No of Pages : 93

Synopsis
The global Biopharmaceutical Excipients market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Excipients.
Report Scope
The Biopharmaceutical Excipients market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BASF SE
ABITEC Corp
Colorcon, Inc
DFE Pharma
Meggle AG
Pharmonix Biological
Roquette
Sigachi Industries
Signet Chemical Corporation
Spectrum Chemical Manufacturing Corp
SPI Pharma
Segment by Type
Solubilizers& Surfactants/Emulsifiers
Polyols
Carbohydrates
Other
Segment by Application
Biopharmaceutical Downstream
Biopharmaceutical Upstream
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biopharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biopharmaceutical Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Biopharmaceutical Excipients Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Excipients
1.2 Biopharmaceutical Excipients Segment by Type
1.2.1 Global Biopharmaceutical Excipients Market Value Comparison by Type (2024-2030)
1.2.2 Solubilizers& Surfactants/Emulsifiers
1.2.3 Polyols
1.2.4 Carbohydrates
1.2.5 Other
1.3 Biopharmaceutical Excipients Segment by Application
1.3.1 Global Biopharmaceutical Excipients Market Value by Application: (2024-2030)
1.3.2 Biopharmaceutical Downstream
1.3.3 Biopharmaceutical Upstream
1.4 Global Biopharmaceutical Excipients Market Size Estimates and Forecasts
1.4.1 Global Biopharmaceutical Excipients Revenue 2019-2030
1.4.2 Global Biopharmaceutical Excipients Sales 2019-2030
1.4.3 Global Biopharmaceutical Excipients Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biopharmaceutical Excipients Market Competition by Manufacturers
2.1 Global Biopharmaceutical Excipients Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biopharmaceutical Excipients Average Price by Manufacturers (2019-2024)
2.4 Global Biopharmaceutical Excipients Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biopharmaceutical Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biopharmaceutical Excipients, Product Type & Application
2.7 Biopharmaceutical Excipients Market Competitive Situation and Trends
2.7.1 Biopharmaceutical Excipients Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biopharmaceutical Excipients Players Market Share by Revenue
2.7.3 Global Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biopharmaceutical Excipients Retrospective Market Scenario by Region
3.1 Global Biopharmaceutical Excipients Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biopharmaceutical Excipients Global Biopharmaceutical Excipients Sales by Region: 2019-2030
3.2.1 Global Biopharmaceutical Excipients Sales by Region: 2019-2024
3.2.2 Global Biopharmaceutical Excipients Sales by Region: 2025-2030
3.3 Global Biopharmaceutical Excipients Global Biopharmaceutical Excipients Revenue by Region: 2019-2030
3.3.1 Global Biopharmaceutical Excipients Revenue by Region: 2019-2024
3.3.2 Global Biopharmaceutical Excipients Revenue by Region: 2025-2030
3.4 North America Biopharmaceutical Excipients Market Facts & Figures by Country
3.4.1 North America Biopharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biopharmaceutical Excipients Sales by Country (2019-2030)
3.4.3 North America Biopharmaceutical Excipients Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biopharmaceutical Excipients Market Facts & Figures by Country
3.5.1 Europe Biopharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biopharmaceutical Excipients Sales by Country (2019-2030)
3.5.3 Europe Biopharmaceutical Excipients Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biopharmaceutical Excipients Market Facts & Figures by Country
3.6.1 Asia Pacific Biopharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biopharmaceutical Excipients Sales by Country (2019-2030)
3.6.3 Asia Pacific Biopharmaceutical Excipients Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biopharmaceutical Excipients Market Facts & Figures by Country
3.7.1 Latin America Biopharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biopharmaceutical Excipients Sales by Country (2019-2030)
3.7.3 Latin America Biopharmaceutical Excipients Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biopharmaceutical Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Biopharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biopharmaceutical Excipients Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biopharmaceutical Excipients Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biopharmaceutical Excipients Sales by Type (2019-2030)
4.1.1 Global Biopharmaceutical Excipients Sales by Type (2019-2024)
4.1.2 Global Biopharmaceutical Excipients Sales by Type (2025-2030)
4.1.3 Global Biopharmaceutical Excipients Sales Market Share by Type (2019-2030)
4.2 Global Biopharmaceutical Excipients Revenue by Type (2019-2030)
4.2.1 Global Biopharmaceutical Excipients Revenue by Type (2019-2024)
4.2.2 Global Biopharmaceutical Excipients Revenue by Type (2025-2030)
4.2.3 Global Biopharmaceutical Excipients Revenue Market Share by Type (2019-2030)
4.3 Global Biopharmaceutical Excipients Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biopharmaceutical Excipients Sales by Application (2019-2030)
5.1.1 Global Biopharmaceutical Excipients Sales by Application (2019-2024)
5.1.2 Global Biopharmaceutical Excipients Sales by Application (2025-2030)
5.1.3 Global Biopharmaceutical Excipients Sales Market Share by Application (2019-2030)
5.2 Global Biopharmaceutical Excipients Revenue by Application (2019-2030)
5.2.1 Global Biopharmaceutical Excipients Revenue by Application (2019-2024)
5.2.2 Global Biopharmaceutical Excipients Revenue by Application (2025-2030)
5.2.3 Global Biopharmaceutical Excipients Revenue Market Share by Application (2019-2030)
5.3 Global Biopharmaceutical Excipients Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BASF SE
6.1.1 BASF SE Corporation Information
6.1.2 BASF SE Description and Business Overview
6.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BASF SE Biopharmaceutical Excipients Product Portfolio
6.1.5 BASF SE Recent Developments/Updates
6.2 ABITEC Corp
6.2.1 ABITEC Corp Corporation Information
6.2.2 ABITEC Corp Description and Business Overview
6.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ABITEC Corp Biopharmaceutical Excipients Product Portfolio
6.2.5 ABITEC Corp Recent Developments/Updates
6.3 Colorcon, Inc
6.3.1 Colorcon, Inc Corporation Information
6.3.2 Colorcon, Inc Description and Business Overview
6.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Colorcon, Inc Biopharmaceutical Excipients Product Portfolio
6.3.5 Colorcon, Inc Recent Developments/Updates
6.4 DFE Pharma
6.4.1 DFE Pharma Corporation Information
6.4.2 DFE Pharma Description and Business Overview
6.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DFE Pharma Biopharmaceutical Excipients Product Portfolio
6.4.5 DFE Pharma Recent Developments/Updates
6.5 Meggle AG
6.5.1 Meggle AG Corporation Information
6.5.2 Meggle AG Description and Business Overview
6.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Meggle AG Biopharmaceutical Excipients Product Portfolio
6.5.5 Meggle AG Recent Developments/Updates
6.6 Pharmonix Biological
6.6.1 Pharmonix Biological Corporation Information
6.6.2 Pharmonix Biological Description and Business Overview
6.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pharmonix Biological Biopharmaceutical Excipients Product Portfolio
6.6.5 Pharmonix Biological Recent Developments/Updates
6.7 Roquette
6.6.1 Roquette Corporation Information
6.6.2 Roquette Description and Business Overview
6.6.3 Roquette Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roquette Biopharmaceutical Excipients Product Portfolio
6.7.5 Roquette Recent Developments/Updates
6.8 Sigachi Industries
6.8.1 Sigachi Industries Corporation Information
6.8.2 Sigachi Industries Description and Business Overview
6.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sigachi Industries Biopharmaceutical Excipients Product Portfolio
6.8.5 Sigachi Industries Recent Developments/Updates
6.9 Signet Chemical Corporation
6.9.1 Signet Chemical Corporation Corporation Information
6.9.2 Signet Chemical Corporation Description and Business Overview
6.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolio
6.9.5 Signet Chemical Corporation Recent Developments/Updates
6.10 Spectrum Chemical Manufacturing Corp
6.10.1 Spectrum Chemical Manufacturing Corp Corporation Information
6.10.2 Spectrum Chemical Manufacturing Corp Description and Business Overview
6.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolio
6.10.5 Spectrum Chemical Manufacturing Corp Recent Developments/Updates
6.11 SPI Pharma
6.11.1 SPI Pharma Corporation Information
6.11.2 SPI Pharma Biopharmaceutical Excipients Description and Business Overview
6.11.3 SPI Pharma Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.11.4 SPI Pharma Biopharmaceutical Excipients Product Portfolio
6.11.5 SPI Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biopharmaceutical Excipients Industry Chain Analysis
7.2 Biopharmaceutical Excipients Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biopharmaceutical Excipients Production Mode & Process
7.4 Biopharmaceutical Excipients Sales and Marketing
7.4.1 Biopharmaceutical Excipients Sales Channels
7.4.2 Biopharmaceutical Excipients Distributors
7.5 Biopharmaceutical Excipients Customers
8 Biopharmaceutical Excipients Market Dynamics
8.1 Biopharmaceutical Excipients Industry Trends
8.2 Biopharmaceutical Excipients Market Drivers
8.3 Biopharmaceutical Excipients Market Challenges
8.4 Biopharmaceutical Excipients Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’